CANTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Thursday reported a loss of $27.6 million in its fourth quarter.
The Canton, Massachusetts-based company said it had a loss of $1.02 per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.07 per share.
The specialty pharmaceutical company posted revenue of $1.3 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $1.8 million.
Collegium Pharmaceutical shares have dropped 0.5 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $15.49, a drop of 13 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL
Keywords: Collegium Pharmaceutical, Earnings Report